# DeFi Technologies

Type: Company (DEFI)

Source: GetYourBrief — https://getyourbrief.com/entity/defi-technologies
Canonical HTML page: https://getyourbrief.com/entity/defi-technologies

## Timeline

- **2026-Q4**: Potential Extension — Aptorum may apply for a second 180-day period if compliance is not met but criteria are satisfied.
- **2026-09-02**: Initial Compliance Deadline — End of the first 180-day grace period to regain a $1.00 closing bid price.
- **2026-03-06**: Deficiency Notice Received — Nasdaq notifies Aptorum of non-compliance with the $1.00 minimum bid price rule.

## Recent coverage (4 stories, network-wide)

### DeFi Technologies Q2 Call: Crypto Equity Read-Through Amid Mistras $193M
2026-08-16 02:08:54 · Sector: crypto · Sentiment: Neutral · Impact: 5/10 · Sources: 3

DeFi Technologies' Q2 earnings call appeared alongside industrial results from Mistras and TransAct, but details were limited. The cluster highlights why public crypto equities face scrutiny as investors seek fundamental revenue and treasury metrics.
Full story: https://getcryptobrief.com/story/defi-technologies-q2-2026-crypto-earnings

### Mistras Q2 EBITDA Hits Record $25.8M; TransAct Underlying Sales Rise 8%
2026-08-16 02:07:43 · Sector: finance · Sentiment: Neutral · Impact: 5/10 · Sources: 3

Mistras Group posted a record second-quarter adjusted EBITDA of $25.8 million on 4.2% revenue growth, while TransAct Technologies raised full-year guidance after underlying sales rose 8% excluding tariff refunds.
Full story: https://getfinancebrief.com/story/mistras-transact-q2-2026-earnings-finance

### Nasdaq Issues Delisting Warnings to Aptorum and DeFi Technologies
2026-03-06 22:25:29 · Sector: finance · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Aptorum and DeFi Technologies have received formal deficiency notices from Nasdaq for failing to maintain the $1.00 minimum bid price requirement. Both companies now face a 180-day deadline to regain compliance or risk being delisted to the over-the-counter markets.
Full story: https://getfinancebrief.com/story/nasdaq-delisting-warnings-aptorum-defi-technologies

### Aptorum Faces Nasdaq Delisting Risk Amid Minimum Bid Price Deficiency
2026-03-06 22:24:58 · Sector: bio · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Aptorum Group Limited (APM) has received a formal deficiency notice from Nasdaq for failing to maintain the $1.00 minimum bid price required for continued listing. The company now enters a critical 180-day window to regain compliance, highlighting the ongoing financial pressures facing small-cap clinical-stage biotech firms.
Full story: https://getbiobrief.com/story/aptorum-nasdaq-minimum-bid-price-deficiency

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getyourbrief.com/guides/methodology for the full editorial methodology.